D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Duopharma Biotech Bhd
Total Equity Peer Comparison

Comparables:
P
PLABS
A
AHEALTH
R
RHONEMA
Y
YSPSAH
K
KOTRA

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Total Equity
myr694m
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
14%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Total Equity
myr78.1m
CAGR 3-Years
4%
CAGR 5-Years
9%
CAGR 10-Years
10%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Total Equity
myr918.3m
CAGR 3-Years
24%
CAGR 5-Years
18%
CAGR 10-Years
14%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Total Equity
myr166.9m
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Total Equity
myr397.9m
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
6%
K
Kotra Industries Bhd
KLSE:KOTRA
Total Equity
myr263m
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
8%

See Also

What is Duopharma Biotech Bhd's Total Equity?
Total Equity
694m MYR

Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's Total Equity amounts to 694m MYR.

What is Duopharma Biotech Bhd's Total Equity growth rate?
Total Equity CAGR 10Y
14%

Over the last year, the Total Equity growth was 3%. The average annual Total Equity growth rates for Duopharma Biotech Bhd have been 4% over the past three years , 7% over the past five years , and 14% over the past ten years .

Back to Top